Journal Information
Vol. 222. Issue 1.
Pages 37-41 (January 2022)
Share
Share
Download PDF
More article options
Visits
1510
Vol. 222. Issue 1.
Pages 37-41 (January 2022)
Brief Original
CURB-65 as a predictor of 30-day mortality in patients hospitalized with COVID-19 in Ecuador: COVID-EC study
CURB-65 como predictor de mortalidad a 30 días enpacientes hospitalizados con COVID-19 en Ecuador: estudio COVID-EC
Visits
1510
J. Carriela,f,
Corresponding author
jorge.carriel84@gmail.com

Corresponding author.
, R. Muñoz-Jaramillob, O. Bolaños-Ladinezc, F. Heredia-Villacresesc, J. Menéndez-Sanchónd, J. Martin-Delgadoe, COVID-EC Researh Group 1
a Servicio de Medicina Interna, Hospital Universitario La Zarzuela, Madrid, Spain
b Servicio de Gastroenterología, Hospital IESS Ceibos, Guayaquil, Ecuador
c Servicio de Medicina Intensiva, Servicio de Cardiología, Hospital Clínica San Francisco, Guayaquil, Ecuador
d Servicio de Medicina Interna, Hospital General Guasmo Sur, Guayaquil, Ecuador
e Grupo de Investigación Atenea, Fundación para el Fomento de la Investigación Sanitaria y Biomédica, San Juan de Alicante, Alicante, Spain
f Instituto de Investigación e Innovación en Salud integral, Facultad de Ciencias Médicas, Universidad Católica de Santiago de Guayaquil, Guayaquil, Ecuador
Related content
Rev Clin Esp. 2022;222:42-310.1016/j.rceng.2021.08.001
V. Estrada, J. González del Castillo
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (1)
Tables (1)
Table 1. Univariate and multivariate analysis of independent factors associated with morality.
Additional material (1)
Abstract
Objective

This article aims to assess the utility of CURB-65 in predicting 30-day mortality in adult patients hospitalized with COVID-19.

Methods

This work is a cohort study conducted between March 1 and April 30, 2020 in Ecuador.

Results

A total of 247 patients were included (mean age 60 ± 14 years, 70% men, overall mortality 41.3%). Patients with CURB-65 ≥ 2 had a higher mortality rate (57 vs. 17%, p < .001) that was associated with other markers of risk: advanced age, hypertension, overweight/obesity, kidney failure, hypoxemia, requirement for mechanical ventilation, or onset of respiratory distress.

Conclusions

CURB-65  ≥ 2 was associated with higher 30-day mortality on the univariate (Kaplan–Meier estimator) and multivariate (Cox regression) analysis.

Keywords:
Pneumonia
Coronavirus
SARS-CoV-2
COVID-19
CURB-65
Mortality
Resumen
Objetivo

Valorar la utilidad del CURB-65 para predecir la mortalidad a 30 días en pacientes adultos hospitalizados con COVID-19.

Métodos

Cohorte realizada entre el 1 de marzo y el 30 de abril de 2020 en Ecuador.

Resultados

Se incluyeron 247 pacientes (edad media 60 ± 14 años, 70% varones, mortalidad global 41,3%). Los pacientes con CURB-65 ≥ 2 presentaron mayor mortalidad (57 vs. 17%, p < 0,001), en asociación con otros marcadores de riesgo: edad avanzada, hipertensión arterial, sobrepeso/obesidad, fracaso renal, hipoxemia, requerimiento de ventilación mecánica o desarrollo de distrés respiratorio.

Conclusiones

En el análisis univariado (Kaplan–Meier) y multivariado (regresión de Cox) el CURB-65 ≥ 2 se relacionó con una mayor mortalidad a 30 días.

Palabras clave:
Neumonía
Coronavirus
SARS-CoV-2
COVID-19
CURB-65
Mortalidad

Article

These are the options to access the full texts of the publication Revista Clínica Española (English Edition)
Member
Si es usted socio de FESEMI siga los siguientes pasos:

Diríjase desde aquí a la web de la >>>FESEMI<<< e inicie sesión mediante el formulario que se encuentra en la barra superior, pulsando sobre el candado.

Una vez autentificado, en la misma web de FESEMI, en el menú superior, elija la opción deseada.

>>>FESEMI<<<

Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Revista Clínica Española (English Edition)

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
Email
Idiomas
Revista Clínica Española (English Edition)
Article options
Tools
Supplemental materials
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?